$BDPT
BIOADAPTIVES, INC.

2022 Q4 Form 10-Q Financial Statement

#000164033422002451 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $3.980K $3.337K $5.342K
YoY Change 3.38% -37.53% 20.34%
Cost Of Revenue $2.950K $1.337K $2.227K
YoY Change 8.86% -39.96% -34.27%
Gross Profit $1.030K $2.000K $3.115K
YoY Change -9.65% -35.79% 196.38%
Gross Profit Margin 25.88% 59.93% 58.31%
Selling, General & Admin $27.65K $74.57K $131.4K
YoY Change -79.84% -43.25% 411.05%
% of Gross Profit 2684.47% 3728.5% 4217.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $690.00 $4.470K $44.58K
YoY Change -98.35% -89.97%
% of Gross Profit 66.99% 223.5% 1431.14%
Operating Expenses $28.34K $79.05K $176.0K
YoY Change -84.16% -55.08% 584.41%
Operating Profit -$27.31K -$77.05K -$172.9K
YoY Change -84.63% -55.43% 600.94%
Interest Expense -$980.00 $94.11K $64.54K
YoY Change -97.32% 45.8% -2.52%
% of Operating Profit
Other Income/Expense, Net -$199.3K $138.3K
YoY Change -244.05% 1135.48%
Pretax Income -$28.28K -$276.3K -$34.52K
YoY Change -86.8% 700.59% 156.38%
Income Tax
% Of Pretax Income
Net Earnings -$28.28K -$276.3K -$34.52K
YoY Change -86.8% 700.57% 156.38%
Net Earnings / Revenue -710.55% -8280.64% -646.13%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$3.093K -$1.021K
COMMON SHARES
Basic Shares Outstanding 160.5M shares 103.8M shares 33.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.45K $17.94K $66.68K
YoY Change -69.39% -73.1% 349.33%
Cash & Equivalents $25.41K $17.91K $66.34K
Short-Term Investments $40.00 $30.00 $340.00
Other Short-Term Assets $0.00 $0.00 $1.000K
YoY Change -100.0% -100.0%
Inventory $8.877K $8.000K $9.601K
Prepaid Expenses $0.00 $0.00 $1.000K
Receivables
Other Receivables
Total Short-Term Assets $34.32K $25.94K $77.28K
YoY Change -61.38% -66.43% 141.42%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.990K $3.674K $101.4K
YoY Change -94.99% -96.38%
TOTAL ASSETS
Total Short-Term Assets $34.32K $25.94K $77.28K
Total Long-Term Assets $2.990K $3.674K $101.4K
Total Assets $37.31K $29.62K $178.7K
YoY Change -74.89% -83.43% 458.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.939K $5.340K $190.5K
YoY Change 296.51% -97.2% 171.2%
Accrued Expenses $1.015K $2.622K $55.31K
YoY Change -90.77% -95.26%
Deferred Revenue
YoY Change
Short-Term Debt $392.0K $434.1K $479.9K
YoY Change -10.25% -9.54% 3.42%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.489M $1.625M $1.391M
YoY Change 19.91% 16.86% 8.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.489M $1.625M $1.391M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.489M $1.625M $1.391M
YoY Change 19.91% 16.86% 8.24%
SHAREHOLDERS EQUITY
Retained Earnings -$7.552M -$7.523M -$6.442M
YoY Change 13.45% 16.79%
Common Stock $25.26K $13.29K $3.580K
YoY Change 396.95% 271.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.452M -$1.596M -$1.212M
YoY Change
Total Liabilities & Shareholders Equity $37.31K $29.62K $178.7K
YoY Change -74.89% -83.43% 458.25%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$28.28K -$276.3K -$34.52K
YoY Change -86.8% 700.57% 156.38%
Depreciation, Depletion And Amortization $690.00 $4.470K $44.58K
YoY Change -98.35% -89.97%
Cash From Operating Activities -$27.50K -$66.61K -$33.18K
YoY Change -22.32% 100.75% -3.77%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 35.00K 35.00K 30.00K
YoY Change -32.69% 16.67% -33.23%
NET CHANGE
Cash From Operating Activities -27.50K -66.61K -33.18K
Cash From Investing Activities
Cash From Financing Activities 35.00K 35.00K 30.00K
Net Change In Cash 7.500K -31.61K -3.180K
YoY Change -54.82% 894.03% -130.43%
FREE CASH FLOW
Cash From Operating Activities -$27.50K -$66.61K -$33.18K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Revenues
Revenues
3337 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
403117 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
33715 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001575142
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50819780 shares
CY2021Q4 us-gaap Liabilities
Liabilities
1241624 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50819780 shares
CY2021Q4 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
10000 shares
bdpt Expected Dividend Yield
ExpectedDividendYield
0 pure
CY2021 bdpt Expected Dividend Yield
ExpectedDividendYield
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021Q4 bdpt Common Stock Shares Outstanding1
CommonStockSharesOutstanding1
50809780 shares
CY2021Q4 bdpt Common Stock Shares Issued1
CommonStockSharesIssued1
132925864 shares
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Entity File Number
EntityFileNumber
000-54949
dei Entity Registrant Name
EntityRegistrantName
BioAdaptives Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2592228
dei Entity Address Address Line1
EntityAddressAddressLine1
2620 Regatta Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89128
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
659-8829
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
160487511 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17909 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82936 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
190 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
4750 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
88876 usd
CY2021Q4 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
59709 usd
CY2021Q4 us-gaap Assets
Assets
148585 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
247750 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
557042 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6862 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13333 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1241624 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50819780 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132935864 shares
CY2022Q3 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
10000 shares
CY2021Q3 us-gaap Revenues
Revenues
5342 usd
us-gaap Revenues
Revenues
13192 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1337 usd
us-gaap Cost Of Revenue
CostOfRevenue
6962 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
3115 usd
us-gaap Gross Profit
GrossProfit
6096 usd
us-gaap Gross Profit
GrossProfit
8963 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43981 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
110456 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
236698 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
152776 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
30588 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
20929 usd
us-gaap Professional Fees
ProfessionalFees
102532 usd
us-gaap Professional Fees
ProfessionalFees
58551 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
163900 usd
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
4476 usd
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44583 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
61464 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
92083 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
79045 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
175968 usd
us-gaap Operating Expenses
OperatingExpenses
400694 usd
us-gaap Operating Expenses
OperatingExpenses
467310 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-31 usd
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-423 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-158 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-106 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
94106 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
64543 usd
us-gaap Interest Expense
InterestExpense
199572 usd
us-gaap Interest Expense
InterestExpense
141792 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-105143 usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
203303 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-272965 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-184420 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-199280 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
138337 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-472695 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-377318 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-276325 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-34516 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-867293 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-835665 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-276325 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-34516 usd
us-gaap Net Income Loss
NetIncomeLoss
-867293 usd
us-gaap Net Income Loss
NetIncomeLoss
-835665 usd
CY2022Q3 bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.00
CY2021Q3 bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.00
bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.01
bdpt Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
-0.03
CY2022Q3 bdpt Weighted Average Number Of Share Outstanding Of Basic And Diluted
WeightedAverageNumberOfShareOutstandingOfBasicAndDiluted
89333996 shares
CY2021Q3 bdpt Weighted Average Number Of Share Outstanding Of Basic And Diluted
WeightedAverageNumberOfShareOutstandingOfBasicAndDiluted
33818539 shares
bdpt Weighted Average Number Of Share Outstanding Of Basic And Diluted
WeightedAverageNumberOfShareOutstandingOfBasicAndDiluted
77615330 shares
bdpt Weighted Average Number Of Share Outstanding Of Basic And Diluted
WeightedAverageNumberOfShareOutstandingOfBasicAndDiluted
31687123 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1093039 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
52017 usd
CY2022Q1 bdpt Adjustments To Additional Paid In Capital Other Debts Forgiveness Related Party
AdjustmentsToAdditionalPaidInCapitalOtherDebtsForgivenessRelatedParty
10000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5429 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-223837 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1494946 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
175413 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-276325 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1595858 usd
CY2021Q1 bdpt Stock Issued During Value Settlement For Debt
StockIssuedDuringValueSettlementForDebt
75000 usd
CY2021Q1 bdpt Series A Preferred Stock Issued For License Fee Amount
SeriesAPreferredStockIssuedForLicenseFeeAmount
102500 usd
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
486612 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
163900 usd
CY2021Q1 bdpt Stock Cancelled During Period Value
StockCancelledDuringPeriodValue
0 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-491903 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1042676 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-309246 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1351922 usd
CY2021Q3 bdpt Series A Preferred Stock Issued For License Fee Amount
SeriesAPreferredStockIssuedForLicenseFeeAmount
91000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
83152 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-34516 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1212286 usd
us-gaap Net Income Loss
NetIncomeLoss
-867293 usd
us-gaap Net Income Loss
NetIncomeLoss
-835665 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
569764 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
61464 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
92083 usd
us-gaap Share Based Compensation
ShareBasedCompensation
163900 usd
bdpt Warrant Issued For Patents Acquisition
WarrantIssuedForPatentsAcquisition
5429 usd
bdpt Warrant Issued For Patents Acquisition
WarrantIssuedForPatentsAcquisition
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
272965 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
184420 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
193500 usd
bdpt Issuance Series A Preferred Stock For Settlement Of Debt Related Party
IssuanceSeriesAPreferredStockForSettlementOfDebtRelatedParty
0 usd
bdpt Issuance Series A Preferred Stock For Settlement Of Debt Related Party
IssuanceSeriesAPreferredStockForSettlementOfDebtRelatedParty
60 usd
bdpt Debts Forgiveness Related Party
DebtsForgivenessRelatedParty
10000 usd
bdpt Debts Forgiveness Related Party
DebtsForgivenessRelatedParty
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
161221 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
98481 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
51000 usd
bdpt Unrealized Loss On Investments In Marketable Securities
UnrealizedLossOnInvestmentsInMarketableSecurities
158 usd
bdpt Unrealized Loss On Investments In Marketable Securities
UnrealizedLossOnInvestmentsInMarketableSecurities
106 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3250 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4214 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
172177 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
119213 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1803 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-199755 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-123248 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1623 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1623 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1623 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1623 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25272 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
160000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
205000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134728 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
185000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-65027 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
61752 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82936 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4587 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17909 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66339 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
4728 usd
us-gaap Interest Paid Net
InterestPaidNet
16424 usd
bdpt Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
142000 usd
bdpt Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
120000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
349045 usd
bdpt Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
142000 usd
bdpt Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
44933 usd
bdpt Settled On Issuance Of Common Stock
SettledOnIssuanceOfCommonStock
-180912 usd
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
228032 usd
bdpt Cancellation Of Common Stock
CancellationOfCommonStock
0 usd
bdpt Cancellation Of Common Stock
CancellationOfCommonStock
35 usd
bdpt Owned Subsidiaries Percentage
OwnedSubsidiariesPercentage
1 pure
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
32 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
791095 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
190 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
557042 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7523402 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
32 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
190 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
59709 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
47500 usd
CY2022Q2 bdpt Asset Value Of License Cost
AssetValueOfLicenseCost
0 usd
CY2021Q4 bdpt Asset Value Of License Cost
AssetValueOfLicenseCost
59709 usd
bdpt Amortization Of Intangible Assets1
AmortizationOfIntangibleAssets1
1755 usd
CY2022Q2 bdpt Asset Value Of The Patent
AssetValueOfThePatent
3674 usd
bdpt Ending Balance
EndingBalance
791095 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5340 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1750 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
300000 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
166666 usd
CY2022Q3 bdpt Accrued Interest Current
AccruedInterestCurrent
92282 usd
CY2021Q4 bdpt Accrued Interest Current
AccruedInterestCurrent
68341 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2622 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10993 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
400244 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
247750 usd
CY2022Q3 bdpt Total Convertible Notes Payable
TotalConvertibleNotesPayable
430750 usd
CY2021Q4 bdpt Total Convertible Notes Payable
TotalConvertibleNotesPayable
416450 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6862 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13333 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
423888 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
403117 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
423888 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
403117 usd
CY2022Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
37903 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
41847 usd
CY2022Q3 bdpt Convertible Notes Accrued Interest
ConvertibleNotesAccruedInterest
91320 usd
CY2021Q4 bdpt Convertible Notes Accrued Interest
ConvertibleNotesAccruedInterest
63100 usd
bdpt Amortization Of Debt Discount
AmortizationOfDebtDiscount
161221 usd
bdpt Amortization Of Debt Discount
AmortizationOfDebtDiscount
98481 usd
us-gaap Debt Instrument Convertible If Converted Value In Excess Of Principal
DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
158450 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
9683 usd
bdpt Convertible Shares Of Common Stock
ConvertibleSharesOfCommonStock
82116084 shares
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
180912 usd
bdpt Debt Discount
DebtDiscount
186933 usd
bdpt Debt Discount
DebtDiscount
142000 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
44933 usd
bdpt Beginning Balance
BeginningBalance
557042 usd
bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
44933 usd
bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
143392 usd
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
228032 usd
bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
41028 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
272965 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
184420 usd
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 bdpt Preferred Stock Shares Par Value
PreferredStockSharesParValue
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
82116084 shares
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
349045 usd
CY2022Q3 bdpt Common Stock Shares Issued1
CommonStockSharesIssued1
132925864 shares
CY2022Q3 bdpt Common Stock Shares Outstanding1
CommonStockSharesOutstanding1
50809780 shares
CY2022Q3 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
10000 shares
CY2022Q1 bdpt Common Stock Shares Granted
CommonStockSharesGranted
1000000 shares
CY2022Q1 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.006
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5429 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.35 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0131 pure
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
25272 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
20000 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
4728 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
0 usd
us-gaap Interest Paid
InterestPaid
448 usd
us-gaap Interest Paid
InterestPaid
1464 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
8443 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
33715 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
961 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5241 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.04 pure
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
133334 usd
bdpt Increase Decrease In Accrued Salaries Payable
IncreaseDecreaseInAccruedSalariesPayable
10000 usd

Files In Submission

Name View Source Status
0001640334-22-002451-index-headers.html Edgar Link pending
0001640334-22-002451-index.html Edgar Link pending
0001640334-22-002451.txt Edgar Link pending
0001640334-22-002451-xbrl.zip Edgar Link pending
bdpt-20220930.xsd Edgar Link pending
bdpt_10q.htm Edgar Link pending
bdpt_10qimg1.jpg Edgar Link pending
bdpt_ex311.htm Edgar Link pending
bdpt_ex312.htm Edgar Link pending
bdpt_ex321.htm Edgar Link pending
bdpt_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bdpt-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bdpt_10q_htm.xml Edgar Link completed
bdpt-20220930_pre.xml Edgar Link unprocessable
bdpt-20220930_def.xml Edgar Link unprocessable
bdpt-20220930_cal.xml Edgar Link unprocessable